Navigation Search

SALIENTVALUE


6 Directions For The New Addictions Rx Marketplace

By Tom Schramski, PhD, CMAA Volume 4 Issue 25, December 5, 2017  Nearly 50 years ago, Anais Nin wrote that “we don’t see things as they are, we see things as we are.” Her observation about human projection fits well for the addictions treatment market where we are in the midst of continuing evolution. One of the…

READ MORE

5 Reasons ASCs Are Dominating The Healthcare Marketplace

By Hilsman Knight, Managing Director Volume 4 Issue 24, November 21, 2017  Ambulatory Surgery Centers (ASCs) have rapidly become an preferred option for outpatient procedure services. As a result, the procedures that had been traditionally preformed in hospital settings have been transitioning more to the ASC model and previously designated inpatient procedures are now classified as outpatient…

READ MORE

7 Faces Of The Coming I/DD Revolution

By Tom Schramski, PhD, CMAA, Joshua Boynton, CMAA, Drew Smith, MBA, and Kelly Friedlander, MSW, MPA Volume 4 Issue 23, November 7, 2017  During the past 50 years, we have experienced profound change in the services and support for people with intellectual/developmental disabilities. Many large, costly, and dehumanizing institutions have closed, while community supports promoting inclusion and self-direction have blossomed…

READ MORE

7 Critical Market Trends DME/HME Executives Need To Consider Today

By Bradley Smith, ATP, CMAA Volume 4 Issue 22, October 24, 2017  The rapidly evolving DME/HME market continues to grow in volume despite significant downward pressure from insurers. This market has experienced significant consolidation in recent years, in part as a result of fee schedule changes introduced by the Centers for Medicare & Medicaid Services (CMS). Further…

READ MORE

9 Great Reasons To Hire A Healthcare M+A Advisor

By Teresa Gonzalo, PharmD, PHD, MBA, CMAA Volume 4 Issue 21, October 10, 2017  From time to time I am asked the following question: Why should I hire a specialized merger and acquisition advisor or investment banker for my healthcare company? A simple answer would be, because it´s a win-win situation for all the parties involved. A…

READ MORE

The 5 Silver Linings Of Value-Based I/DD Services

By Joshua Boynton Volume 4 Issue 20, September 26, 2017  Created in 1965, the Federal Medicaid program today covers 74 million people in the US, with expenditures of over $500 billion each year. Within this population are five million people with an intellectual/developmental disability (I/DD), 700,000 of which are receiving financial support through the Home and Community-Based…

READ MORE

5 Mind-Blowing Scenarios Of The New Healthcare Marketplace

By Tom Schramski, PhD, CMAA Volume 4 Issue 19, September 12, 2017  Amid the unknown of public healthcare financing, our new healthcare marketplace is rapidly evolving. This transformation is fueled by several interrelated developments: Innovation in service models The expanded use of technology in clinical delivery and operations Increased consumerism and private healthcare spending The demand for transparency in healthcare offerings The growing desire…

READ MORE

5 Reasons Why We Should Demand Price Transparency In Healthcare

By Tom Schramski, PhD, CMAA Volume 4 Issue 18, August 29, 2017  In 2016, Ohio passed the Healthcare Price Transparency Law, which would force healthcare providers to give patients a “good faith” estimate for non-emergency service expenses after considering insurance reimbursement. The Ohio Hospital Association, among others, has successfully fought implementation to date with claims that the…

READ MORE

Is Private Equity Money Worth The Hassle?

By Bradley Smith , ATP, CMAA and Hilsman Knight Volume 4 Issue 17, August 15, 2017  Money is money, right? While that’s undoubtedly true, investment money always comes with strings attached. Private equity groups, venture capital, and personal investors are all looking to achieve certain growth and revenue targets. For example, venture capital notoriously likes the capability to replace…

READ MORE

7 Ways The IC Model Is Transforming The I/DD Marketplace

By Tom Schramski, PhD, CMAA Volume 4 Issue 16, August 1, 2017  The preponderance of contracted services for people with intellectual/developmental disabilities (I/DD) are provided by the employees of organizations, including nonprofit and for-profit entities. Because many of the services are labor intensive, these employees likely number in the hundreds of thousands nationally, with most in direct…

READ MORE